LASALOCID

ID: ALA4800307

Chembl Id: CHEMBL4800307

PubChem CID: 162677261

Max Phase: Preclinical

Molecular Formula: C34H54O8

Molecular Weight: 590.80

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC[C@H](C(=O)[C@H](C)[C@@H](O)[C@H](C)CCc1ccc(C)c(O)c1C(=O)O)[C@@H]1O[C@@](CC)([C@H]2CC[C@](O)(CC)[C@@H](C)O2)C[C@@H]1C

Standard InChI:  InChI=1S/C34H54O8/c1-9-25(31-21(6)18-34(11-3,42-31)26-16-17-33(40,10-2)23(8)41-26)30(37)22(7)28(35)19(4)12-14-24-15-13-20(5)29(36)27(24)32(38)39/h13,15,19,21-23,25-26,28,31,35-36,40H,9-12,14,16-18H2,1-8H3,(H,38,39)/t19-,21+,22-,23-,25-,26-,28+,31-,33-,34-/m1/s1

Standard InChI Key:  BBMULGJBVDDDNI-YNWAAKSFSA-N

Alternative Forms

  1. Parent:

    ALA4800307

    ---

Associated Targets(non-human)

SARS-CoV-2 (38078 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Vero C1008 (1716 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: YesOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 590.80Molecular Weight (Monoisotopic): 590.3819AlogP: 5.84#Rotatable Bonds: 13
Polar Surface Area: 133.52Molecular Species: ACIDHBA: 7HBD: 4
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 2.64CX Basic pKa: CX LogP: 7.67CX LogD: 4.16
Aromatic Rings: 1Heavy Atoms: 42QED Weighted: 0.23Np Likeness Score: 1.74

References

1. Ellen Van Damme.  (2021)  Screening of ~5500 FDA-approved drugs and clinical candidates for anti-SARS-CoV-2 activity,  [10.6019/CHEMBL4651402]

Source